FAS Wealth Partners’s MDxHealth MDXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$52K Hold
22,625
﹤0.01% 392
2025
Q4
$80.8K Hold
22,625
0.01% 374
2025
Q3
$105K Hold
22,625
0.01% 343
2025
Q2
$50K Hold
22,625
﹤0.01% 369
2025
Q1
$32.1K Sell
22,625
-1,800
-7% -$3.25K ﹤0.01% 357
2024
Q4
$57.9K Buy
24,425
+8,100
+50% +$16.5K ﹤0.01% 342
2024
Q3
$34K Hold
16,325
﹤0.01% 368
2024
Q2
$39K Hold
16,325
﹤0.01% 353
2024
Q1
$42.3K Buy
+16,325
New +$57.2K ﹤0.01% 356

Other funds holding MDXH

FAS Wealth Partners's MDXH Position: Q1 2026 in Review

FAS Wealth Partners held its MDxHealth (MDXH) position steady in Q1 2026 at 22,625 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #392.

FAS Wealth Partners first reported a position in MDXH in Q1 2024 and has held it in 9 quarters since. The position peaked at $105K in Q3 2025. 51 funds tracked by Wall St. Rank hold MDXH as of Q1 2026.

  • FAS Wealth Partners held 22,625 shares of MDxHealth worth $52K as of Q1 2026.
  • FAS Wealth Partners left its MDxHealth share count unchanged in Q1 2026.
  • MDxHealth made up ﹤0.01% of FAS Wealth Partners's portfolio in Q1 2026, its #392 holding.
  • FAS Wealth Partners first reported a position in MDxHealth in Q1 2024 and has held it in 9 quarters since.
  • FAS Wealth Partners's MDxHealth position peaked at $105K in Q3 2025.
  • 51 funds tracked by Wall St. Rank held MDxHealth as of Q1 2026.

Based on FAS Wealth Partners's 13F filing for Q1 2026, filed 10 Jun 2026.